Clinical Trials Logo

Clinical Trial Summary

This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 6-15 months.


Clinical Trial Description

This study was divided into two stages. The first stage study was an early safety assessment study among 80 subjects. The first stage study was conducted gradually in 20 subjects aged 18-50 years, 20 subjects aged 3-17 years, and 40 subjects aged 6-15 months. The second phase was a randomized, double-blind, controlled, non-inferiority phase III clinical trial in 1200 healthy infants aged 6-15 months, to evaluate the immunogenicity and safety of the experimental vaccine after two doses of immunization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04689165
Study type Interventional
Source Chinese Academy of Medical Sciences
Contact Wei Cun, Doctor
Phone +86-13629464497
Email cunwei@foxmail.com
Status Recruiting
Phase Phase 3
Start date September 14, 2020
Completion date December 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04689191 - A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine Phase 3
Completed NCT00780806 - Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults Phase 1/Phase 2
Completed NCT03378258 - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Completed NCT03205371 - Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers Phase 3
Completed NCT01352793 - A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years Phase 3
Not yet recruiting NCT06113198 - A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age Phase 4
Completed NCT03295318 - Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds Phase 2
Completed NCT03493919 - A Sourcing Study to Collect Human Blood Samples From Healthy Adults Phase 4
Completed NCT00474526 - A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants Phase 3
Completed NCT00297687 - Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults Phase 1
Recruiting NCT04665791 - A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults N/A
Withdrawn NCT03431675 - Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 Phase 4
Recruiting NCT02878291 - Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months Phase 1
Completed NCT00314041 - Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants Phase 2
Recruiting NCT04685850 - Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
Completed NCT03587207 - Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years Phase 2
Completed NCT03824093 - High and Low Resource Interventions to Promote HPV Vaccines N/A
Completed NCT04707391 - Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine Phase 3
Terminated NCT00798304 - Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants Phase 2
Recruiting NCT03682939 - Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population Phase 4